Results
eNauka >
Rezultati >
Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study
| Naziv: | Afatinib in locally advanced/metastatic NSCLC harboring common <i>EGFR</i> mutations, after chemotherapy: a Phase IV study | Autori: | Thongprasert, Sumitra; Geater, Sarayut L; Clement, Dana; Abdelaziz, Amr; Reyes-Igama, Jasmin; Jovanovic, Dragana; Alexandru, Aurelia; Schenker, Michael; Sriuranpong, Virote; Serwatowski, Piotr; | Godina: | 2019 | Publikacija: | LUNG CANCER MANAGEMENT | ISSN: | 1758-1966 Lung Cancer Management Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 8 br. 3 | DOI: | 10.2217/lmt-2019-0004 | WoS-ID: | 000511920100002 | URI: | https://enauka.gov.rs/handle/123456789/992287 | Projekat: | AstraZeneca Roche Boehringer Ingelheim Novartis Astra Zeneca Astellas Bristol Myers Squibb Eli Lilly Pfizer AbbVie Merck Merck Serono Bioven Pharma Mar Regeneron Eisai Amgern Mylan |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.